Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Able to sign informed consent

• Possible to obtain fundus imaging

• Acute CSC ˂4 months of duration in one eye, defined as:

‣ Subfoveal presence of SRF on OCT

⁃ Present attack is 1st -3rd attack of CSC

• b) Patient history and examination consistent with acute CSC c) Characteristic appearance of acute CSC on fundus autofluorescence (FAF) and OCT

• Chronic CSC ≥4 months of duration in one eye, defined as:

‣ Subfoveal presence of SRF on OCT

⁃ Subjective visual loss/symptoms

⁃ Characteristic appearance of chronic CSC on FAF, fluorescein angiography (FA), and indocyanin angiography (ICGA) and OCT

⁃ Patient history and examination consistent with chronic CSC

Locations
Other Locations
Norway
Stavanger University Hospital, Department of Ophthalmology
RECRUITING
Stavanger
Contact Information
Primary
Vegard Forsaa, MD PhD
forsaa@gmail.com
+4748152212
Time Frame
Start Date: 2022-10-01
Estimated Completion Date: 2026-07-31
Participants
Target number of participants: 50
Treatments
Acute
Patients with acute first attack CSC with subretinal fluid (SRF) on OCT and symptom duration under 4 months.
Chronic
Patients with chronic CSC, i.e. symptoms and SRF for more than 4 months.
Related Therapeutic Areas
Sponsors
Leads: Helse Stavanger HF

This content was sourced from clinicaltrials.gov